Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Psychopathology
|
January 1, 1987
Distinguishing depressive and negative symptoms in chronic schizophrenia
H A Whiteford, S J Riney, J G Csernansky
Psychiatry Research
|
March 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia
J W Newcomer, S J Riney, S Vinogradov, et al.
Psychopharmacology Bulletin
|
January 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease
J W Newcomer, S J Riney, S Vinogradov, et al.
Acta Psychiatrica Scandinavica
|
January 1, 1988
Dexamethasone nonsuppression in chronic schizophrenia
H A Whiteford, S J Riney, R A Savala, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1987
An adjunctive role for ascorbic acid in the treatment of schizophrenia?
L Beauclair, S Vinogradov, S J Riney, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1989
A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics
P B Hicks, S Vinogradov, S J Riney, et al.
Archives of General Psychiatry
|
July 1, 1988
Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms
J G Csernansky, S J Riney, L Lombrozo, et al.
Military Medicine
|
October 18, 2001
Do post-traumatic stress disorder symptoms worsen during trauma focus group treatment?
J I Ruzek, S J Riney, G Leskin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Psychopathology
|
January 1, 1987
Distinguishing depressive and negative symptoms in chronic schizophrenia
H A Whiteford, S J Riney, J G Csernansky
Psychiatry Research
|
March 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia
J W Newcomer, S J Riney, S Vinogradov, et al.
Psychopharmacology Bulletin
|
January 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease
J W Newcomer, S J Riney, S Vinogradov, et al.
Acta Psychiatrica Scandinavica
|
January 1, 1988
Dexamethasone nonsuppression in chronic schizophrenia
H A Whiteford, S J Riney, R A Savala, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1987
An adjunctive role for ascorbic acid in the treatment of schizophrenia?
L Beauclair, S Vinogradov, S J Riney, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1989
A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics
P B Hicks, S Vinogradov, S J Riney, et al.
Archives of General Psychiatry
|
July 1, 1988
Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms
J G Csernansky, S J Riney, L Lombrozo, et al.
Military Medicine
|
October 18, 2001
Do post-traumatic stress disorder symptoms worsen during trauma focus group treatment?
J I Ruzek, S J Riney, G Leskin, et al.
Page
of 1